
Transcranial Photobiomodulation (tPBM) is an advanced, non-invasive brain therapy that uses red and near-infrared light to stimulate brain cells and support neurological function. By delivering specific wavelengths of light through the scalp and skull, tPBM aims to enhance cellular energy production, improve circulation, reduce inflammation, and support the brain’s natural repair and recovery processes.
This therapy is increasingly used in cognitive optimization, neuro-rehabilitation, preventive brain health, and longevity-focused medicine.
tPBM delivers low-level red and near-infrared light into targeted regions of the brain. The light penetrates the tissues and interacts with mitochondria — the energy-producing structures within cells.
This process may help increase ATP production (cellular energy), improve cerebral blood flow, reduce oxidative stress, support neuroplasticity, and promote cellular repair and regeneration.
The therapy is completely non-invasive, painless, and does not generate harmful heat or radiation.
tPBM is commonly used to support:
Research and clinical applications are also exploring its role in supporting individuals with neurological and neurodegenerative conditions such as:
While ongoing scientific research is promising, tPBM should be considered a supportive therapy and not a replacement for conventional medical care.
Transcranial Photobiomodulation may benefit individuals seeking:
It is suitable for adults of all ages and is increasingly integrated into wellness, integrative medicine, neuro-rehabilitation, and longevity programs.
During a session, a specialized light device or helmet is placed over targeted regions of the head. Sessions are relaxing, painless, and typically last between 15 and 30 minutes.
Many individuals describe the treatment as calming and mentally refreshing.
With repeated sessions, potential benefits may include:
Results vary depending on the individual, goals, and clinical condition, but benefits generally develop progressively over a structured treatment program.